Allos Therapeutics, Inc. (Nasdaq: ALTH) today reported results from a retrospective analysis of data from the Company's pivotal PROPEL trial, which assessed the safety and efficacy of single-agent FOLOTYN® (pralatrexate injection) as a second-line treatment in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) who received CHOP as their first-line treatment...
Heart Disease Beats Breast Cancer As The Biggest Killer, UK
6/19/2011
Breast cancer accounts for almost a third of all cancer cases reported in women. However advances in the treatment for breast cancer, and early detection, have improved the chances of survival from the disease...
For decades, researchers have been working to develop nanoparticles that deliver cancer drugs directly to tumors, minimizing the toxic side effects of chemotherapy. However, even with the best of these nanoparticles, only about 1 percent of the drug typically reaches its intended target...
Researchers from The George Washington University School of Medicine and Health Sciences (SMHS) have been awarded a five-year, $500,000-per-year R01 grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH). This award will support investigations by SMHS researchers who are developing proteomic biomarkers for Opisthorchis-induced bile duct cancer...
Colon Cancer Metastasis Inhibited By Tapeworm Drug
6/19/2011
A compound that for about 60 years has been used as a drug against tapeworm infection is also apparently effective against colon cancer metastasis, as studies using mice have now shown. The compound silences a gene that triggers the formation of metastases in colon cancer...
Sunscreens - FDA Moves To Help Consumers Be Better Informed
6/19/2011
In a move to help consumers become better informed so they can select the right sunscreen for their type of skin and circumstance, the Food and Drug Administration is altering how OTC (over-the-counter, non-prescription) sunscreens are marketed in America. The FDA adds that the new regulations will not be enforced for another twelve months...
Lung Cancer Death Rate Falling Faster In Men Than Women, USA
6/18/2011
The overall drop in death rates means 898,000 individuals who would have died from lung cancer over the last 17 years did not, according to a report issued by the American Cancer Society. From 2001 to 2007 male lung cancer deaths fell by 1.9% annually, while for women from 2002 to the end of 2007 rates dropped by 1.5% per year...
Pfizer Injectables, part of Pfizer Inc.'s (NYSE: PFE) Established Products Business Unit, announced the addition of doxorubicin hydrochloride injection, USP, to Pfizer Injectables' growing portfolio of off-patent oncology products...
PDA Stresses Importance Of Screenings To Detect Oral Cancer
6/18/2011
Oral cancer claims more lives than leukemia, Hodgkin's lymphoma, laryngeal cancer, testicular cancer, thyroid cancer, or skin cancer. In 2010, approximately 36,540 Americans were diagnosed with this largely preventable type of cancer that affects the mouth and throat; 7,880 died of the disease. Early detection is essential to dramatically reduce the number of deaths from oral cancer...
Discovery Of A New Mechanism Of Gene Control That Is Associated With Cancer
6/18/2011
Scientists at Memorial Sloan-Kettering Cancer Center in New York and at IRB Barcelona reveal the mechanism of action of a protein that is essential for life and is associated with disease...